Comment
This critical incident could be considered as the consequence of the anaesthesiologist's failure to apply basic knowledge. However, similar dif®culties have been observed elsewhere. In two cases of mechanical occlusion of the respiratory circuit, 4 5 the ®rst hypothesis made by anaesthesiologists with regard to the origin of restricted ventilation was bronchospasm. The true cause of the problem was only discovered by disconnecting the patient from the respiratory circuit and obtaining an appropriate oxygenation using a self-in¯ating bag.
In most cases, the problem is not the individual but the system. Our analysis shows that occlusion was possible because the ®lter had a hydrophobic membrane and was placed below the patient's head. The ability of the anaesthesiologists to detect airway ®lter occlusion was limited by the lack of information on the risk associated with the use of this device and by its position under the drapes. The identi®cation of latent failures that are organizational root causes of accidents or critical incidents is, therefore, essential for devising appropriate corrective actions.
At ®rst glance, our strategy, which combines prevention and absorption, could be perceived as convoluted. Compared with the prevailing approach of risk management which, as noted by Cooper, 6 `d epends almost solely on the anaesthetist's ability to react instinctively and¯awlessly every time a problem arises', this method is much more ef®cient. Indeed, if Po is the probability of airway ®lter occlusion and Pr the probability of not recognizing in time the problem, PoQPr will be the probability Pc of the critical incident. As a consequence, any x-fold decrease in both Po and Pr will have a multiplicative effect and result in a x 2 -fold decrease of Pc whereas a x-fold decrease in Pr alone will only cause an equivalent decrease in Pc.
Given the usefulness of root-cause analysis with regard to patient safety, it is clear that we should systematically investigate critical incidents and accidents. However, reporting and analysis of such events on a routine basis and setting up appropriate corrective actions will require considerable cultural and organizational changes. Is there any alternative? Methods. In this pilot study we measured cGMP in the saliva of six healthy volunteers and eight patients undergoing general anaesthesia for minor gynaecological procedures. Samples were obtained using a commercially available sampling device and cGMP was determined with an enzyme immunoassay and results expressed as a cGMP per mg protein.
References
Results. There was no statistically signi®cant variation in salivary cGMP either day-to-day or between time points in healthy volunteers. Analysis of variance of salivary cGMP of patients undergoing general anaesthesia showed that cGMP increased signi®cantly intraoperatively and returned to preoperative levels after surgery (P=0.03).
Conclusions. This is the ®rst time that real time in vivo changes in salivary cGMP levels during general anaesthesia in humans have been demonstrated and may allow an alternative technique for measuring depth of anaesthesia in the future. This has been disputed and not been reported in chronic administration and deletion of the type I (neuronal) nitric oxide synthase gene. 2 3 cGMP is detectable in saliva, providing an easily accessible sample for measurement during anaesthesia. There are no previous data regarding variation in salivary cGMP in healthy subjects in the absence of anaesthesia, and therefore initial studies assessing any variation were required before undertaking studies in anaesthetized subjects. The aim of this study was to assess whether changes in salivary cGMP occurred during anaesthesia in humans.
Methods and results
Following local ethics approval and written informed consent we collected saliva from six healthy volunteers (25±32 yr) on 5 consecutive days at two time points (10:00 and 15:00 h) using a commercially available collection device, OrasureÔ (Altrix Healthcare, Birkenhead, Merseyside, UK). We also collected saliva from eight ASA grade I or II patients (24±36 yr) undergoing minor obstetric procedures, immediately prior to induction, 10 min into the procedure and within 60 min after the operation. The anaesthetic regimen was standardized. All patients received induction of anaesthesia with propofol and maintenance with iso¯urane/nitrous oxide in oxygen at 1.3 MAC via a facemask without the use of an airway. None of the patients had any form of pre-medication or received intraoperative opioids.
Saliva samples were frozen in liquid nitrogen immediately after collection and stored at ±80°C until analysis. For the assay, samples were thawed on ice and microwaved for 8 s to halt enzyme activity. 4 5 cGMP concentrations were determined using a sensitive enzyme immunoassay kit (R&D Systems Europe, Abingdon, Oxon, UK) as described previously. 5 Protein was measured using Bradford reagent (Sigma-Aldrich, Poole, Dorset, UK) and results were expressed as saliva cGMP pmol (mg protein) ±1 . Data were analysed using Friedman analysis of variance with Wilcoxon signed ranks post hoc testing as appropriate and Bonferroni correction for multiple comparisons as necessary.
There was no statistically signi®cant variation in salivary cGMP either day-to-day or between time points in healthy volunteers. In patients, analysis of variance revealed a statistically signi®cant change in cGMP (P=0.03) during anaesthesia and surgery with no change in salivary protein concentration. Post hoc analysis showed that cGMP increased signi®cantly intraoperatively (P=0.023) and returned to preoperative levels following surgery (Fig. 1) .
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Our data show that concentrations of cGMP in saliva remain constant during normal activity and change during anaesthesia. Confounding variables were reduced to a minimum by choosing a group of patients who were essentially healthy, having minor obstetric surgeryÐthus all patients were female and of a very narrow age range. In addition, all the operations took place at a similar time of day, with the same anaesthetist, and the duration of the operation was similar (10±15 min). The anaesthetic regimen was standar-dized, with identical procedures for all patients, no premedication drugs and no opioid usage. Thus, changes in cGMP are more reliably related to anaesthesia and not other factors.
Studies in anaesthetized animals have shown decreases in cGMP within the central nervous system after halothane or iso¯urane anaesthesia. 5 However, in the present study, salivary cGMP increased during anaesthesia compared with concentrations immediately pre-induction. This may be partially explained by nitric oxide synthase activity or haemoxygenase activity during anaesthesia. Both nitric oxide, produced by the action of nitric oxide synthase, and carbon monoxide, the product of haemoxygenase activity, are potent activators of soluble guanyl cyclase. 6 The results of this study need to be extended to a larger study of various anaesthetic techniques to establish whether this is a common link for a mechanism of anaesthesia in humans. Also, the possible development of a`real time' cGMP monitor is appealing and may allow an alternative technique for measuring depth of anaesthesia.
